Awareness of Prediabetes Status and Subsequent Health Behavior, Body Weight, and Blood Glucose Levels

References

1. 1.↵
   American Diabetes Association and National Institute of Diabetes, Digestive and Kidney Diseases. The prevention or delay of type 2 diabetes. Diabetes Care 2002;25:742–9.

   OpenUrlFREE Full Text
2. 2.↵
   Centers for Disease Control and Prevention. National Diabetes Statistics Report, 2017. Atlanta, GA: Centers for Disease Control and Prevention, US Dept of Health and Human Services; 2017. Available from: https://www.cdc.gov/diabetes/data/statistics/statistics-report.html. Accessed August 2018.
3. 3.↵
   1. Ogurtsova K,
   2. da Rocha Fernandes JD,
   3. Huang Y,
   4. et al

   . IDF Diabetes Atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract 2017;128:40–50.

   OpenUrlCrossRefPubMed
4. 4.↵
   American Diabetes Association. Standards of medical care in diabetes—2018. Diabetes Care 2018;41:S1–S155.

   OpenUrlFREE Full Text
5. 5.↵
   World Health Organization. Diabetes mellitus: report of a WHO Study Group. Tech. Rep. Ser. 1985, no. 727. Geneva, World Health Organization; 1985.
6. 6.↵
   1. Nathan DM,
   2. Davidson MB,
   3. DeFronzo RA,
   4. et al

   . Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care 2007;30:753–9.

   OpenUrlFREE Full Text
7. 7.↵
   1. Brannick B,
   2. Wynn A,
   3. Dagogo-Jack S

   . Prediabetes as a toxic environment for the initiation of microvascular and macrovascular complications. Exp Biol Med (Maywood) 2016;241:1323–31.

   OpenUrlCrossRefPubMed
8. 8.↵
   1. Brannick B,
   2. Dagogo-Jack S

   . Prediabetes and cardiovascular disease: pathophysiology and interventions for prevention and risk reduction. Endocrinol Metab Clin North Am 2018;47:33–50.

   OpenUrl
9. 9.↵
   1. Knowler WC,
   2. Barrett-Connor E,
   3. Fowler SE,
   4. et al

   . Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393–403.

   OpenUrlCrossRefPubMedWeb of Science
10. 10.↵
    1. Li G,
    2. Zhang P,
    3. Wang J,
    4. et al

    . Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study. Lancet Diabetes Endocrinol 2014;2:474–80.

    OpenUrl
11. 11.↵
    1. Lindström J,
    2. Ilanne-Parikka P,
    3. Peltonen M,
    4. Aunola S,
    5. Eriksson JG,
    6. Hemiö K

    . Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet 2006;368:1673–9.

    OpenUrlCrossRefPubMedWeb of Science
12. 12.↵
    1. Perreault L,
    2. Pan Q,
    3. Mather KJ,
    4. et al

    . Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study. Lancet 2012;379:2243–51.

    OpenUrlCrossRefPubMedWeb of Science
13. 13.↵
    Diabetes Prevention Program Research Group. Achieving weight and activity goals among Diabetes Prevention Program lifestyle participants. Obes Res 2004;12:1426–34.

    OpenUrlCrossRefPubMedWeb of Science
14. 14.↵
    Centers for Disease Control and Prevention. Self-reported prediabetes and risk-reduction activities—United States, 2006. MMWR Morb Mortal Wkly Rep 2008;57:1203–5.

    OpenUrlPubMed
15. 15.↵
    1. Bardenheier BH,
    2. Cogswell ME,
    3. Gregg EW,
    4. Williams DE,
    5. Zhang Z,
    6. Geiss LS

    . Does knowing one's elevated glycemic status make a difference in macronutrient intake? Diabetes Care 2014;37:3143–9.

    OpenUrlAbstract/FREE Full Text
16. 16.↵
    1. Dagogo-Jack S,
    2. Edeoga E,
    3. Ebenibo S,
    4. Chapp-Jumbo E

    . Pathobiology of prediabetes in a bi-racial cohort (POP-ABC) study: baseline characteristics of enrolled subjects. J Clin Endocrinol Metab 2013;98:120–8.

    OpenUrlCrossRefPubMed
17. 17.↵
    1. Dagogo-Jack S,
    2. Edeoga C,
    3. Ebenibo S,
    4. Nyenwe E,
    5. Wan J

    ; for the Pathobiology of Prediabetes in a Biracial Cohort (POP-ABC) Research Group. Lack of racial disparity in incident prediabetes and glycemic progression among black and white offspring of parents with type 2 diabetes: the Pathobiology of Prediabetes in a Biracial Cohort (POP-ABC) Study. J Clin Endocrinol Metab 2014;99:E1078–87.

    OpenUrlCrossRefPubMed
18. 18.↵
    1. Krista AR,
    2. Shattuck AL,
    3. Henry HJ

    . Patterns of dietary behavior associated with selecting diets low in fat: reliability and validity of a behavioral approach to dietary assessment. J Am Diet Assoc 1990;90:214–20.

    OpenUrlPubMedWeb of Science
19. 19.↵
    1. Kriska AM,
    2. Knowler WC,
    3. LaPorte RE,
    4. et al

    . Development of questionnaire to examine relationship of physical activity and diabetes in Pima Indians. Diabetes Care 1990;13:401–11.

    OpenUrlAbstract/FREE Full Text
20. 20.↵
    1. Boucher AB,
    2. Adesanya EAO,
    3. Owei I,
    4. et al

    . Dietary habits and leisure-time physical activity in relation to adiposity, dyslipidemia, and incident dysglycemia in the Pathobiology of Prediabetes in A Biracial Cohort Study. Metabolism 2015;64:1060–7.

    OpenUrl
21. 21.↵
    1. Parsons HM

    . What Happened at Hawthorne?: new evidence suggests the Hawthorne effect resulted from operant reinforcement contingencies. Science 1974;183:922–1932.

    OpenUrlAbstract/FREE Full Text
22. 22.↵
    1. Cizza G,
    2. Piaggi P,
    3. Rother KI,
    4. Csako G

    ; Sleep Extension Study Group. Hawthorne effect with transient behavioral and biochemical changes in a randomized controlled sleep extension trial of chronically short-sleeping obese adults: implications for the design and interpretation of clinical studies. PLoS One 2014 Aug 20;9:e104176.

    OpenUrl
23. 23.↵
    1. McCambridge J,
    2. Witton J,
    3. Elbourne DR

    . Systematic review of the Hawthorne effect: new concepts are needed to study research participation effects. J Clin Epidemiol 2014;3:267–77.

    OpenUrl
24. 24.↵
    1. Yu R,
    2. Chen L

    . The need to control for regression to the mean in social psychology studies. Front Psychol 2015;5:1574.

    OpenUrl
25. 25.↵
    1. Linden A

    . Assessing regression to the mean effects in health care initiatives. BMC Med Res Methodol 2013;13:119.

    OpenUrlCrossRefPubMed
26. 26.↵
    1. Mainous AG,
    2. Tanner RJ,
    3. Baker R

    . Prediabetes diagnosis and treatment in primary care. J Am Board Fam Med 2016;29:283–5.

    OpenUrlAbstract/FREE Full Text